Wall Street Access Asset Management, LLC Dynavax Technologies Corp Transaction History

Wall Street Access Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$4.32 - $11.7 $52,488 - $142,155	-12,150 Closed	0 $0
Q2 2020 Nov 02, 2021	BUY	$2.94 - $9.1 $35,721 - $110,565	12,150 New	12,150 $107,000
Q2 2019 Aug 13, 2019	SELL	$3.65 - $7.89 $55,845 - $120,717	-15,300 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$8.14 - $13.28 $8,140 - $13,280	1,000 Added 6.99%	15,300 $140,000
Q1 2018 May 15, 2018	BUY	$14.65 - $19.9 $14,650 - $19,900	1,000 Added 7.52%	14,300 $283,000
Q4 2017 Feb 15, 2018	BUY	$17.3 - $24.08 $41,520 - $57,791	2,400 Added 22.02%	13,300 $248,000
Q3 2017 Nov 15, 2017	BUY	$15.2 - $21.5 $165,680 - $234,350	10,900	10,900 $234,000

288

131M

507K

374K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.69B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Wall Street Access Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wall Street Access Asset Management, LLC with notifications on news.